Lidofast Gel 1% Lidocaina cloridrato 100g

Gel based on lidocaine hydrochloride.

Therapeutic indications

Lidofast Gel is used in the case of esophagoscopic intubation and for curaric anesthesia, tracheobronchoscopies, pharyngoscopies, gastroscopies, rectoscopies and all endoscopic investigations of an exploratory and curative nature. By associating the lubricating action with the anesthetic action, the product avoids spastic reactions and reflexes that depart from the mucous membranes with which the instruments come into contact during endoscopic maneuvers.

Dosage and Posology

The drug should be taken according to the following doses and methods: carefully spread a layer of product on the instrument before introducing it.

The neutrality of the vehicle of both formulations of the product, its complete solubility in water and the absence of fatty substances mean that, even with continued use of Lidofast, the lenses of the instruments used for the various types of maneuvers do not cloud. their rubber parts deteriorate

Overdose

Symptoms of overdose are characterized by neuroexcitatory manifestations (tremors, convulsions followed by depression, respiratory failure and coma) and by cardiovascular changes with hypotension and bradycardia.

Contraindications

• Hypersensitivity to the active substance or to any of the excipients
• Generally contraindicated in pregnancy and lactation

Side effects

Locally, hypersensitivity reactions characterized by pain, burning and itching can occur. Systemic reactions are generally rare; however, hypersensitivity reactions up to anaphylactic shock may occur.

Pregnancy and breastfeeding

Studies in rats and rabbits revealed no risk to the fetus. Safe use in humans has not been established. This should be borne in mind before administration to pregnant women, especially during the early stages. Since lidocaine is distributed in breast milk, the use of topical preparations, especially if applied to the tracheobronchial mucosa, should be used with caution in breastfeeding women.

Special warnings

The efficacy and safety of lidocaine depend on correct dosage and application technique. It is therefore necessary to use the minimum quantity of the preparation sufficient to obtain the desired effect, applying it with caution in subjects with severely damaged mucous membranes or seat of inflammatory processes and sepsis which could cause excessive absorption of the active ingredient. Excessive absorption of lidocaine can cause side effects affecting the central nervous system and the cardiovascular system, especially in children, the elderly and debilitated subjects. Therefore, it is necessary to be very careful in the use of Lidofast in these subjects.

However, the application for very prolonged periods should be avoided. Products for topical application, especially if used for a prolonged time or repeatedly, can give rise to sensitization phenomena. In this case it is necessary to suspend the treatment and institute a suitable therapy. The product contains para-hydroxy-benzoates which can cause allergic reactions, generally of the delayed type, such as contact dermatitis; more rarely, immediate reactions with urticaria and bronchospasm. The product contains sodium benzoate which is a mild irritant of the skin, eyes, mucous membranes; it may also increase the risk of jaundice in infants.

Expiry and retention

Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored. It is recommended to use the contents within two months of opening the tube.

Warning : do not use the medicine after the expiry date indicated on the package.

Composition

100 gr of Lidofast Gel contain:

Active principle

Lidocaine hydrochloride g 1

Excipients

Sodium carboxymethylcellulose; glycerol; methyl parahydroxybenzoate; propyl parahydroxybenzoate; sodium benzoate; purified water.